Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Alignment Healthcare amends charter, stockholders vote on proposals

EditorAhmed Abdulazez Abdulkadir
Published 06/13/2024, 08:26 PM
© Reuters.
ALHC
-

Alignment Healthcare, Inc. (NASDAQ:ALHC), a provider of hospital and medical service plans, has amended its corporate charter to include a new provision that limits the liability of certain officers, as per an 8-K filing with the U.S. Securities and Exchange Commission (SEC). The amendment aligns with Delaware state law and became effective with the filing of the Certificate of Amendment on June 11, 2024.

The company's stockholders approved the officer exculpation amendment during the annual meeting held on June 7, 2024. The amendment was one of several items on the agenda, which also included the election of Class III directors, ratification of the company's independent auditor, and a non-binding advisory vote on executive compensation.

The four Class III directors were elected with a majority of votes, with Yon Jorden, John Kao, Joseph Konowiecki, and Margaret McCarthy set to serve a three-year term until the 2027 annual meeting. The results of the vote for the directors ranged from 141,784,781 votes in favor for Joseph Konowiecki to 154,436,508 votes for John Kao.

Furthermore, the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified with an overwhelming majority of 181,626,313 votes in favor.

The advisory vote on the executive compensation of the company's named executive officers, also known as the "say-on-pay" vote, passed with 138,403,746 votes in favor, against 21,289,607 votes, with 5,882 abstentions.

The filing did not include any forward-looking statements or marketing material, focusing strictly on the outcomes of the votes and the legal changes to the company's governance structure. The information provided is based on the SEC filing and reflects the company's commitment to comply with applicable laws and regulations, as well as transparency with its stockholders.

In other recent news, Alignment Healthcare has seen significant developments. BofA Securities upgraded the company's stock from Neutral to Buy, citing improved visibility into the company's margin progression. The firm also increased the price target to $11.00, reflecting the company's strategic shift towards improving margins.

Meanwhile, Piper Sandler also upgraded Alignment Healthcare's stock from Neutral to Overweight, following the company's robust first-quarter results for 2024 and a revised full-year 2024 guidance. The new price target of $8.00 is based on a 25-fold multiple applied to the company's projected higher adjusted EBITDA for the 2026 calendar year.

In the first quarter of 2024, Alignment Healthcare reported a 50% increase in health plan membership and a 43% rise in total revenue. The company's adjusted EBITDA was better than anticipated despite being negative. The company is raising its full-year guidance and narrowing its adjusted EBITDA range, aiming for at least a 20% increase in health plan membership and margin expansion in 2025.

InvestingPro Insights

As Alignment Healthcare, Inc. (NASDAQ:ALHC) continues to adapt its corporate governance in line with legal requirements and shareholder preferences, investors may also consider the financial metrics and market performance of the company. According to InvestingPro data, Alignment Healthcare's market capitalization stands at approximately $1.55 billion USD. Despite significant revenue growth over the last twelve months as of Q1 2024, with an increase of 31.76%, the company faces challenges reflected in its negative P/E ratio of -9.96, indicating that it is currently unprofitable.

InvestingPro Tips suggest that analysts have revised their earnings expectations downwards for the upcoming period and do not anticipate the company will be profitable this year. Additionally, the company is trading at a high Price/Book multiple of 11.83, which may be a point of consideration for value-oriented investors. On a positive note, Alignment Healthcare has experienced a strong return over the last three months, with a 62.0% increase in its price total return.

For investors seeking a deeper analysis, there are additional InvestingPro Tips available at https://www.investing.com/pro/ALHC. By using the coupon code PRONEWS24, investors can get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking further insights that can inform investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.